OptimistFi research archive
Latest stock research
Company developments, investment-case changes and tests of market narratives. Every story links to the evidence behind it.
Follow @optimistfidesk on X- APLD · Financing · Market narrative audits ·
Applied Digital Corporation (NASDAQ: APLD) Has a 0.83x Interest Test
Adjusted EBITDA covered 83% of quarterly interest expense. New rent can close the gap, but the current quarter did not.
- URGN · Price move · Investor guides ·
UroGen Pharma Ltd. (NASDAQ: URGN) Stock Is Down 12%: The Investment Case
ZUSDURI is scaling fast enough to bring the business near operating break-even, while cash burn and financing claims still decide the equity case.
- ATMU · Financing · Market narrative audits ·
Can Atmus Filtration Technologies Inc. (NYSE: ATMU) Use Cash Flow to Cut Debt?
Quarterly free cash flow doubled, but Koch Filter financing lifted debt and interest expense, making balance-sheet repair the next test.
- LITE · Price move · Why it moved ·
Why Is Lumentum Holdings Inc. (NASDAQ: LITE) Stock Up This Year?
Lumentum's shares have more than doubled in 2026 and are trading above $1,000. An Nvidia deal, a jump in sales and two new product lines explain the rally. Whether it lasts depends on those new products turning into revenue on time.
- BNO · Guidance · Market narrative audits ·
United States Brent Oil Fund, LP (NYSE Arca: BNO) Tracks a Supply Gap
OPEC+ left November targets unchanged. Its seven core members were still producing about 16.7% below February's prewar level in August.
- TKNO · Legal & regulatory · Market narrative audits ·
Alpha Teknova, Inc. (NASDAQ: TKNO) Adds Regulatory Support for PluriFreeze
A Drug Master File can simplify customer filings, but FDA does not approve DMFs and Teknova has not disclosed PluriFreeze revenue.
- META · Product · Market narrative audits ·
Meta Platforms, Inc. (NASDAQ: META) Has a Conditional $18 Billion Bill
About $5.3 billion depends on rival-platform action, while Meta expects a roughly $10 billion third-quarter expense and payments over a decade.
- IPSC · Clinical & FDA · Market narrative audits ·
Century Therapeutics, Inc. (NASDAQ: IPSC) Adds Two CNTY-813 Batches
Five clinical-scale runs now support consistent manufacturing, up from three in June. The program still has no human safety or efficacy data.
- APLD · Company news · Market narrative audits ·
Applied Digital Corporation (NASDAQ: APLD) Brings 250 MW Online
A new 75 MW phase puts 62.5% of Polaris Forge 1's contracted capacity into service. Rent and cash conversion remain the next test.
- AMD · Price move · Investor guides ·
Why Is Advanced Micro Devices, Inc. (NASDAQ: AMD) Stock Up 188% This Year?
Advanced Micro Devices, Inc. (NASDAQ: AMD) turned AI commitments into faster Data Center growth, but deployment, margins and potential dilution now carry a much higher burden.
- ON · Deal · Market narrative audits ·
ON Semiconductor Corporation (NASDAQ: ON) Cuts Its Deal Cost by 19%
The revised agreement removes planned share dilution, but a $2.45 billion term loan creates a new balance-sheet test.
- GEVO · Earnings · Market narrative audits ·
Gevo, Inc. (NASDAQ: GEVO) Turns $70 Million of Credits Into Cash
The 2026 credit sales equal 78% of first-half revenue, but the cash depends on a federal incentive and does not erase Gevo's funding risk.
APLD
URGN
ATMU
LITE
BNO
TKNO
META
IPSC
AMD
ON
GEVOOptimistFi research · free
Get every new article by email
Each time we publish, it comes to your inbox: the company, the headline and what changed, with a link to the full piece.
Several articles in a day come together in one email, at most once a day. Unsubscribe in one click.